‘When you see there is a fire in someone’s house, will you help or sit still?’ said Mr. Yat-Gai Au, CEO of Regencell Bioscience. That is his strongly worded analogy to the company’s recent announcement to the COVID-19 treatment. The treatment was founded by Mr. Au’s father, who is an established traditional Chinese medicine practitioner with over 30 years of clinical and R&D experience. Throughout the years, Mr. Au is deeply influenced by his father and has seen many patients recover from all sorts of illnesses, disorders and diseases, and he eventually set up Regencell Bioscience in 2014 as he strongly believed that the formulae should be more readily available to help more people and he has made it his mission to research and develop the formulae in hopes of bringing this game-changing formula to more patients around the world.
Our company is very committed to being socially responsible and to improve and save lives. We want to save lives not only by donation but also to provide treatment. Regencell Bioscience Holdings Limited recently entered into a Joint Venture to offer Covid-19 treatment and we strongly believe that our formulae can make a difference in the fight against COVID-19 and bring treatment to those directly in need.